Pre-order Enquiry
Request Free Sample
Global Blood Stream Infection Testing Market Size, Status and Forecast 2019-2025
SKU ID : QYR-14454983 | Publishing Date : 16-Jul-2019 | No. of pages : 96
Request Sample
Request Customization
Check Discounts
BSIs occur when any causative organism enters the bloodstream through a wound, injection, or during a surgical procedure. BSI testing is done to detect the cause of these infections.
Bloodstream infections are mostly diagnosed by blood culture tests and molecular tests. Commercially available tests are SepsiTest, SeptiFast, MagicPlex, VYOO, and PLEX-ID. The global bloodstream infection testing market is driven by the growing incidence and prevalence of burn/wounds cases, HIV, pneumonia, pyelonephritis, and cancer. Additionally, awareness about hygiene, diagnosis rate, unhealthy lifestyle, and increase in geriatric population are the potential factors for the market growth. On the other hand, rigid regulatory scenario regarding diagnosis procedures, high diagnosis cost, and lack of medical reimbursement may hinder the growth of the market during the forecast period. Innovations, R&D investments, mergers and acquisitions among the key vendors are the dynamics for the bloodstream infection testing market to progress.
North America accounts for the largest market share of the global market owing to factors such as high infection rate, increase in awareness, high diagnosis rate, favorable medical reimbursement scenario, and developed medical facilities. It is followed by Europe in terms of market share. Asia Pacific is anticipated to hold the third largest market share owing to large population pool and poor hygienic sense. Latin America and Middle East & Africa are the silent contributors of the market.
In 2018, the global Blood Stream Infection Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Blood Stream Infection Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Blood Stream Infection Testing development in United States, Europe and China.
The key players covered in this study
BD
bioMérieux
Cepheid
Roche Diagnostics
IRIDICA
Bruker
Nanosphere
Siemens
AdvanDX
Market segment by Type, the product can be split into
Conventional Blood Culture Tests
PCR Methods
Nucleic Acid Testing
Mass Spectroscopy
Point of Care Testing
Market segment by Application, split into
Hospitals
Independent Diagnostic Centers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Blood Stream Infection Testing status, future forecast, growth opportunity, key market and key players.
To present the Blood Stream Infection Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Blood Stream Infection Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Bloodstream infections are mostly diagnosed by blood culture tests and molecular tests. Commercially available tests are SepsiTest, SeptiFast, MagicPlex, VYOO, and PLEX-ID. The global bloodstream infection testing market is driven by the growing incidence and prevalence of burn/wounds cases, HIV, pneumonia, pyelonephritis, and cancer. Additionally, awareness about hygiene, diagnosis rate, unhealthy lifestyle, and increase in geriatric population are the potential factors for the market growth. On the other hand, rigid regulatory scenario regarding diagnosis procedures, high diagnosis cost, and lack of medical reimbursement may hinder the growth of the market during the forecast period. Innovations, R&D investments, mergers and acquisitions among the key vendors are the dynamics for the bloodstream infection testing market to progress.
North America accounts for the largest market share of the global market owing to factors such as high infection rate, increase in awareness, high diagnosis rate, favorable medical reimbursement scenario, and developed medical facilities. It is followed by Europe in terms of market share. Asia Pacific is anticipated to hold the third largest market share owing to large population pool and poor hygienic sense. Latin America and Middle East & Africa are the silent contributors of the market.
In 2018, the global Blood Stream Infection Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Blood Stream Infection Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Blood Stream Infection Testing development in United States, Europe and China.
The key players covered in this study
BD
bioMérieux
Cepheid
Roche Diagnostics
IRIDICA
Bruker
Nanosphere
Siemens
AdvanDX
Market segment by Type, the product can be split into
Conventional Blood Culture Tests
PCR Methods
Nucleic Acid Testing
Mass Spectroscopy
Point of Care Testing
Market segment by Application, split into
Hospitals
Independent Diagnostic Centers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Blood Stream Infection Testing status, future forecast, growth opportunity, key market and key players.
To present the Blood Stream Infection Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Blood Stream Infection Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
